Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-030174

Chairman and CEO bought 1,900 shares at $1.29 ($2,451)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-05-14 Purchase +1,400 $1.29 $1,806 10,628,793 D
Niihara Yutaka Chairman and CEO 2020-05-15 Purchase +500 $1.29 $645 10,629,293 D
Open-market purchases · 1,900 sh · avg $1.29 · $2,451
Loading xslF345X03/doc4.xml…